20-34280733-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000687.4(AHCY):​c.*301T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00484 in 445,170 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 32 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 5 hom. )

Consequence

AHCY
NM_000687.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0890

Publications

1 publications found
Variant links:
Genes affected
AHCY (HGNC:343): (adenosylhomocysteinase) S-adenosylhomocysteine hydrolase belongs to the adenosylhomocysteinase family. It catalyzes the reversible hydrolysis of S-adenosylhomocysteine (AdoHcy) to adenosine (Ado) and L-homocysteine (Hcy). Thus, it regulates the intracellular S-adenosylhomocysteine (SAH) concentration thought to be important for transmethylation reactions. Deficiency in this protein is one of the different causes of hypermethioninemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
AHCY Gene-Disease associations (from GenCC):
  • hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 20-34280733-A-C is Benign according to our data. Variant chr20-34280733-A-C is described in ClinVar as [Benign]. Clinvar id is 338267.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0113 (1714/152276) while in subpopulation AFR AF = 0.0381 (1584/41556). AF 95% confidence interval is 0.0366. There are 32 homozygotes in GnomAd4. There are 793 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHCYNM_000687.4 linkc.*301T>G 3_prime_UTR_variant Exon 10 of 10 ENST00000217426.7 NP_000678.1 P23526-1A0A384MTQ3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHCYENST00000217426.7 linkc.*301T>G 3_prime_UTR_variant Exon 10 of 10 1 NM_000687.4 ENSP00000217426.2 P23526-1
AHCYENST00000480653.5 linkn.1748T>G non_coding_transcript_exon_variant Exon 9 of 9 2
AHCYENST00000538132.1 linkc.*301T>G 3_prime_UTR_variant Exon 10 of 10 2 ENSP00000442820.1 P23526-2
ENSG00000250917ENST00000512005.1 linkn.147+294T>G intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.0110
AC:
1672
AN:
152158
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0372
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00563
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.0105
GnomAD4 exome
AF:
0.00150
AC:
440
AN:
292894
Hom.:
5
Cov.:
2
AF XY:
0.00128
AC XY:
200
AN XY:
156334
show subpopulations
African (AFR)
AF:
0.0347
AC:
293
AN:
8450
American (AMR)
AF:
0.00350
AC:
48
AN:
13724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8376
East Asian (EAS)
AF:
0.00
AC:
0
AN:
16104
South Asian (SAS)
AF:
0.000210
AC:
9
AN:
42934
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
15580
Middle Eastern (MID)
AF:
0.00248
AC:
3
AN:
1212
European-Non Finnish (NFE)
AF:
0.000188
AC:
32
AN:
170398
Other (OTH)
AF:
0.00341
AC:
55
AN:
16116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0113
AC:
1714
AN:
152276
Hom.:
32
Cov.:
32
AF XY:
0.0107
AC XY:
793
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0381
AC:
1584
AN:
41556
American (AMR)
AF:
0.00562
AC:
86
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68024
Other (OTH)
AF:
0.0104
AC:
22
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
81
162
244
325
406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00815
Hom.:
2
Bravo
AF:
0.0131
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.6
DANN
Benign
0.60
PhyloP100
0.089
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13245; hg19: chr20-32868539; API